top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Medtronic Leads $100M Strategic Financing Round in Pulnovo Medical

26 minutes ago
1 min read

New York, NY, April 19, 2026 (PRNewswire) -- Pulnovo Medical closed an oversubscribed $100 million strategic financing round led by Medtronic, alongside existing investors EQT, Qiming Venture Partners, OrbiMed, Gaorong Ventures, and Lilly Asia Ventures, and new investor HSG (formerly Sequoia China). Separately, Medtronic and Pulnovo entered into a commercial agreement contemplating potential future commercialization opportunities.

Read full article here.

Recent Posts

Beeline Medicines Launches with $300M Series A to Build Precision Autoimmune Pipeline

Stamford, CT and Boston, MA, April 15, 2026 (Globe Newswire) -- Beeline Medicines officially launched with $300 million in Series A financing led by Bain Capital, debuting with a portfolio of five c

Modulari-T Biosciences Appoints Tanya E. Borsuk as CEO to Lead Next Phase of Growth

Montreal and Highland Park, NJ, April 21, 2026 (Yahoo Finance) -- Modulari-T Biosciences has named Tanya E. Borsuk as its new chief executive officer. The leadership appointment is aimed at advancin

Paratus Names Alicia Secor as CEO and Expands Leadership Team for Growth

Boston, MA, and Singapore, April 22, 2026 (Paratus) -- Paratus Sciences has appointed Alicia Secor as president and chief executive officer. The company also expanded its leadership team to strength

Life Science Headlines

Beeline Medicines Launches with $300M Series A to Build Precision Autoimmune Pipeline

Modulari-T Biosciences Appoints Tanya E. Borsuk as CEO to Lead Next Phase of Growth

Medtronic Leads $100M Strategic Financing Round in Pulnovo Medical

Paratus Names Alicia Secor as CEO and Expands Leadership Team for Growth

Eli Lilly to Acquire Kelonia Therapeutics in Deal Worth Up to $7B to Boost Cancer Pipeline

Embecta to Acquire Owen Mumford in $300M Deal to Expand Drug-Delivery Portfolio

ImpediMed Appoints Erik Anderson as CEO

Neurocrine Biosciences Details $2.9B Deal to Strengthen Pipeline

Hologic names Baxter's Previous Chair Jose Almieda as CEO

Gilead to Acquire Tubulis in $3.15B Deal with Up to $1.85B in Milestones

bottom of page